News, etc.
LATEST PRESS RELEASES
May 21, 2020
MedMira Announces Progress Update of its REVEALCOVID-19TM Total Antibody test including CE mark
Halifax, Nova Scotia, 21. May, 2020 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that it has completed the registration process and affixed the CE mark (Conformité Européene) to its rapid REVEALCOVID-19TM Total Antibody Test.
April 23, 2020
MedMira Announces Notification Submission to US FDA Emergency Use Authorization
MedMira Inc. announced today that it had submitted the notification for the Emergency Use Authorization application offered by the U.S. Food and Drug Administration (FDA) for its newest member of its Reveal line of products for antibody testing.
April 15, 2020
MedMira Announces Development of COVID-19 Point-of-Care Antibody Test
MedMira Announces Update on Development of Point-of-Care Antibody Test
MAR 31, 2020
MedMira Reports Second Quarter Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended March 31, 2020.
DEC 30, 2019
MedMira Reports First Quarter Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2019.
NOV 28, 2019
MedMira Reports 2019 Fourth Quarter and Year End Financial Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for
the financial year ended July 31, 2019.
JUN 29, 2019
MedMira Reports Third Quarter Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2019
MAR 29, 2019
MedMira Reports Second Quarter Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial
results for the quarter ended January 31, 2019.
MAR 28, 2019
Medmira Reports 2018 Fourth Quarter and Year End Financial Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2018.
MAR 14, 2019
Management Cease Trade Order Update
MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.
FEB 5, 2019
Management Cease Trade Order Update
MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.
JAN 22, 2019
Management Cease Trade Order Update
MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.
JAN 8, 2019
Management Cease Trade Order Update
MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.
DEC 28, 2018
Medmira Reports First Quarter Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2018.
DEC 25, 2018
Management Cease Trade Order Update
MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.
DEC 11, 2018
Management Cease Trade Order Update
MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.
NOV 27, 2018
MedMira Inc. Announces Appointment of Auditor and Late Filing of Annual Financial Statements
MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has engaged Arsenault Best Cameron Ellis of Charlottetown, Prince Edward Island, as auditor for the Company’s financial statements for the year ended July 31, 2018.
SEPT 6, 2018
MedMira Announces Revocation of Cease Trade Order
MedMira Inc. (MedMira) (TSXV: MIR), announced that the Nova Scotia Securities Commission has revoked the Cease Trade Order.
JUNE 29, 2018
MedMira Reports Third Quarter Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2018.
MARCH 29, 2018
MedMira Reports Second Quarter Results
MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2018.
FEBRUARY 1, 2018
MedMira Announces AGM Results and Stock Option Grant
MedMira Inc. (MedMira) (TSXV: MIR) held its 2018 Annual General Meeting of Shareholders on January 31, 2018 in Halifax, Nova Scotia.
DECEMBER 22, 2017
MedMira Reports First Quarter Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2017.
NOVEMBER 28, 2017
MedMira Reports 2017 Fourth Quarter and Year End Financial Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter and year ended July 31, 2017.
JUNE 29, 2017
MedMira Reports FY2017 Third Quarter Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and nine month periods ending April 30, 2017.
MAY 1, 2017
MedMira Receives CE Mark for Syphilis/HIV Multipex Rapid Test
MedMira Inc. (MedMira) (TSXV:MIR), has received CE Mark on its syphilis/HIV rapid test, Multiplo TP/HIV.
MARCH 31, 2017
MedMira Reports FY2017 Second Quarter Results
MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and six month periods ending January 31, 2017.
JANUARY 30, 2017
MedMira Announces AGM Results and Stock Option Grant
MedMira Inc. (MedMira) (TSXV:MIR), held its Annual General Meeting of Shareholders on January 27, 2017.